SN
Sanofi
SNY · NASDAQ
$43.16 -0.76% (-$0.33)
1M -0.74%
Market Cap 91.5B €
P/E Ratio 23.12x
Div. Yield 5.46%
ROE 5.52%
Bulios Fair Price
$48.73
12.9% upside
Current Price
$43.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
84 /100
Cheap P/E 23.12x
EV/EBITDA 8.76x
PEG 0.29x
Growth
38 /100
Stable EPS growth 0.21%
Rev. growth 4.82%
Book val. growth 1.54%
Profitability
80 /100
Strong Gross margin 73.02%
Net margin 8.09%
FCF margin 24.06%
Quality
28 /100
Poor ROIC 5.33%
ROE 5.52%
Asset turnover 0.38x
Debt
82 /100
Low Debt/Equity 0.34x
Current ratio 0.99x
Net debt/EBITDA 1.39x
Stability
65 /100
Moderate Beta 0.28x
Rev. volatility 1.98%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
76,493
Headquarters
Paris
Upcoming events
23 OCT
Earnings
Upcoming earnings report